LAS VEGAS, NV , Dec. 14, 2017 -- StereoVision Entertainment, Inc. (OTC PINK: SVSN), a publicly traded Nevada Corporation announced today that their majority-owned medical cannabis/industrial hemp subsidiary CannaVision has signed Dr. Scott Sherman M.D. to head up a CannaVision Medical Cannabis and Pain Management Clinic in Sunrise, Florida.
“We’re happy to welcome Dr. Sherman to CannaVision’s medical staff,” said CannaVision’s Chairman and Chief Medical Officer Dr. Jay Ellenby M.D. “Our primary focus is treating vets and cancer patients and I look forward to working with Dr. Sherman. The Miami medical cannabis clinic market has quickly become overcrowded so we’re moving our Coral Gables clinic operations to Sunrise. With Sunrise centered amidst a number of VA medical facilities and cancer treatment centers this area best serves our purpose.”
StereoVision Entertainment Inc. http://stereovision.com Headquartered in Las Vegas, Nevada StereoVision is a publicly traded Nevada corporation (OTC:SVSN) focused on creating, acquiring, and producing multimedia content with its media subsidiaries, the wholly owned 9 time Emmy Award-winning production company REZN8, http://rezn8.com, the majority-owned family entertainment company, Inspirational Vision Media, Inc. http://ivmi.biz, and the majority-owned medical cannabis clinic and industrial hemp Florida C corporation MediCannaVision Inc., dba CannaVision. http://cannavisionclinics.com
Safe Harbor Statement: Except for historical information certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and those statements are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The Company cautions that these forward-looking statements are qualified by other factors. The Company undertakes no obligation to publicly update any statements in this release.
Contact: Steve Previch 305-972-1030 [email protected]


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Anta Sports Expands Global Footprint With Strategic Puma Stake 



